Loss of motion after knee surgery may increase osteoarthritis risk, research suggests

July 9, 2011

The onset of osteoarthritis may be related to a loss of knee motion after reconstructive ACL surgery, as noted in new research presented at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego, California, July 7-10, 2011. Patients who showed motion limitations after surgery were more likely to develop arthritic changes in the knee.

"Our research shows that patients given rehabilitation that emphasizes full motion be obtained and maintained throughout time after surgery have more favorable results on than patients who lose motion." said lead researcher K. Donald Shelbourne, MD, Founder, Shelbourne Knee Center.

The study examined data from 780 patients who were at least five years after ACL reconstruction with a patellar tendon graft. In individual follow-ups, patients were evaluated and rated based on knee range of motion tests and radiographs. The percentage of patients with normal radiographs (no arthritic changes in the knee) was 71 percent in patients with normal range of motion compared to 55 percent of patients who showed deficits in motion. In patients who had similar meniscus removal, was observed more in patients who had motion deficits.

"Something like osteoarthritis can be debilitating," said Shelbourne, "and our goal is to continually find new ways to help patients avoid such a problem."

This study adds to previous research identifying major for the development of osteoarthritis after ACL reconstruction, including meniscectomy (removal of the meniscus) and articular cartilage damage.

Explore further: New research points to a possible gender link in knee injuries

Related Stories

Recommended for you

New trials offer hope for TB treatment

October 28, 2016

Researchers at the University of St Andrews are one step closer to finding a shorter, more effective treatment for TB, according to a new paper published by The Lancet Infectious Diseases.

Fatty liver: Turning off TAZ reverses disease

October 27, 2016

Scientists at Columbia University Medical Center (CUMC) have identified a factor in liver cells that is responsible for turning a relatively benign liver condition, present in 30 percent of U.S. adults, into a serious disease ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.